Investment Review – May 2019

May 22, 2019 Investment Review

  1. The major U.S. equity indices all posted gains in April. The Nasdaq Composite increased 4.7%, the S&P 500 added 3.9%, and the Dow Jones Industrial Average rose 2.6%. Following a sell-off in December 2018, the market has regained all-time highs after a strong start to the year.

  2. S&P 500 earnings for the first quarter have been better than expected. Technology and Financials led the market in April. Healthcare was a drag on the market, as investors are concerned with Medicare for All discussions by Democratic Presidential candidates.

  3. April saw a strong IPO market, led by Zoom Video Communications, Beyond Meat and Pinterest. Uber is one of the most anticipated IPOs in recent memory and is expected to be the largest IPO in 5 years. The Biotech sector also had a number of successful IPOs, which should continue through May.

key investment statistics may 2019

Sources: Bloomberg LLC,  FACTSET, Wall Street Journal, U.S. Department of Labor, Federal Reserve, Institute for Supply Management, ISI

Disclosure: This commentary reflects the opinions of Welch & Forbes based on information that we believe to be reliable. It is intended for informational purposes only, and not to suggest any specific performance or results, nor should it be considered investment, financial, tax or other professional advice. It is not an offer or solicitation.

If you would like to receive your copy of the Economic Outlook and Investment Review monthly in the mail, call Ed Sullivan, Vice President, at 617-557-9800, or email him at

Make sure to bookmark our Perspectives webpage so you can stay up to date with the most recent weekly Welch & Forbes insights, announcements, and content. To receive our monthly email digest, simply enter your email address in the banner on this page.

Access your complimentary Wealth Planning Suite

wealth planning suite

Includes your Initial Consultation Portfolio X-Ray© Estate Plan Review Financial Plan

  • This field is for validation purposes and should be left unchanged.

*There is no fee for the Initial Consultation or Portfolio X-Ray© for prospective clients. Portfolio X-Ray© is a Morningstar product that Welch & Forbes maintains a license for its use. The Estate Plan Review and Financial Plan are provided only to clients.